The effect of tranexamic acid on blood transfusion in lower gastrointestinal bleeding—A double blind prospective randomised controlled trial
World Journal of Surgery · 2024
DOI: 10.1002/wjs.12282 ↗At a glance
Randomisierte kontrollierte Studie in World Journal of Surgery, 2024. Written by Avihai Moscovici and 7 co-authors. Institution: Department of Surgery, Shamir Medical Center, Beer Yaacov, Israel. Major MEDLINE topics: Tranexamic Acid, Antifibrinolytic Agents, Gastrointestinal Hemorrhage, Blood Transfusion. Cited 1 times so far (Crossref); 13 references.
Abstract (original language)
Purpose
Acute gastrointestinal bleeding is a common emergency. Tranexamic acid (TXA) reduces clot breakdown by inhibiting the action of plasmin and has been shown to reduce the need for blood transfusion in trauma, surgical procedures, and upper gastrointestinal bleeding. This study examined the efficiency of intravenous TXA in patients with acute lower gastrointestinal bleeding.
Methods
Eighty‐one patients aged >18 years with lower GI hemorrhage, presenting as active rectal bleeding and anemia (hemoglobin lower than 11 g/dL or a decrease of 2 gr/dl from the patient's base level), were enrolled in this single center, double blind prospective research. Patients were randomly assigned to receive intravenous TXA or placebo from admission until colonoscopy took place. The need for transfusion of packed red blood cells (PRBC) and number of units was recorded and compared between the two groups.
Results
Eighty‐one patients were randomized in this study, thirty‐nine in the TXA arm, and forty‐two in the placebo arm. Patient characteristics did not differ between the groups. Forty‐three out of the 81 patients received blood transfusion; twenty‐two were on the placebo arm and twenty‐one on the TXA arm ( p = 0.89). Twenty‐nine patients required 2 or more units, 14 in the TXA arm and 15 in the placebo arm ( p = 0.98).
Conclusions
Intravenous TXA has no significant effect on blood requirement in patients with lower GI bleeding. There was no difference in the consumption of PRBC units among the patients in the placebo and TXA groups. It seems that tranexamic acid has no significant effect on transfusion of PRBC units in lower GI bleeding.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, Shamir Medical Center, Beer Yaacov, Israel.
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID profiles: Avihai Moscovici
Cite
APA
Moscovici, A., Nasasra, A., Hammerschlag, J., Zaharov, R., Kirshtein, A., Dykman, D., Lavy, R., & Zmora, O. (2024). The effect of tranexamic acid on blood transfusion in lower gastrointestinal bleeding—A double blind prospective randomised controlled trial. World Journal of Surgery. https://doi.org/10.1002/wjs.12282
Vancouver
Moscovici A, Nasasra A, Hammerschlag J, Zaharov R, Kirshtein A, Dykman D, et al. The effect of tranexamic acid on blood transfusion in lower gastrointestinal bleeding—A double blind prospective randomised controlled trial. World Journal of Surgery. 2024. doi:10.1002/wjs.12282
BibTeX
@article{Moscovici2024,
author = {Moscovici, Avihai and Nasasra, Ahmad and Hammerschlag, Jonathan and Zaharov, Rafael and Kirshtein, Anna and Dykman, Daniel and Lavy, Ron and Zmora, Oded},
title = {The effect of tranexamic acid on blood transfusion in lower gastrointestinal bleeding—A double blind prospective randomised controlled trial},
journal = {World Journal of Surgery},
year = {2024},
doi = {10.1002/wjs.12282}
}
EUVIMED